Burbach, Pasquesi Co-Author Article on Increased State AG Activity
July 10, 2019
Corporate Counsel
Partners Ed Burbach and Frank Pasquesi have co-authored an article for Corporate Counsel, “2019: New Attorneys General and New Priorities,” about significant recent developments evidencing an increase in state AG activity throughout the country.
The article notes that there are 17 new state attorney generals this year, helping to make up what may be the most racially and gender diverse collection of state attorney generals in history. Moreover, the majority have backgrounds in legislative bodies or state agencies, rather than as prosecutors or in the judiciary, which suggests that policymaking through investigation and enforcement is becoming the norm. And, as those attorney generals become more active, the authors conclude, it is more important than ever to have on-the-ground local state attorney general experience.
(Subscription required.)
The article notes that there are 17 new state attorney generals this year, helping to make up what may be the most racially and gender diverse collection of state attorney generals in history. Moreover, the majority have backgrounds in legislative bodies or state agencies, rather than as prosecutors or in the judiciary, which suggests that policymaking through investigation and enforcement is becoming the norm. And, as those attorney generals become more active, the authors conclude, it is more important than ever to have on-the-ground local state attorney general experience.
(Subscription required.)
People
Related News
July 21, 2025
In the News
Nicholas O'Keefe Assesses 'Golden Share' in US Steel Deal
Foley & Lardner LLP partner Nicholas O'Keefe commented on the 'golden share' arrangement included as part of the approval of Nippon Steel's acquisition of U.S. Steel in Agenda, a Financial Times publication.
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."